Company Intelligence
Axiom Therapeutics
Axiom Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized AI-powered covalent drug discovery for untreatable cancers technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- London, United Kingdom
- Website
- www.axiom-therapeutics.com
- Stage
- Plug and Play
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Axiom Therapeutics is an Enterprise Software AI company based in London, United Kingdom.
Axiom Therapeutics develops AI-powered covalent drug discovery for untreatable cancers.
Axiom Therapeutics is associated with founder(s): Ryan Geiser; Chris Haggard.
What it does
Through the deployment of AI-powered covalent drug discovery for untreatable cancers, Axiom Therapeutics provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
AI-powered covalent drug discovery for untreatable cancers
Why It Matters
Axiom Therapeutics provides enterprise-grade artificial intelligence solutions, delivering specialized AI-powered covalent drug discovery for untreatable cancers technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Axiom Therapeutics
Explore Axiom Therapeutics by Axiom Therapeutics. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Axiom Therapeutics
Industry
Products
People
- Ryan Geiser
- Chris Haggard
Capabilities
- AI-powered covalent drug discovery for untreatable cancers
Features
- AI-powered covalent drug discovery for untreatable cancers
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Axiom Therapeutics do?
Axiom Therapeutics specializes in artificial intelligence, developing AI-powered covalent drug discovery for untreatable cancers to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Axiom Therapeutics based and when was it founded?
Axiom Therapeutics is based in United Kingdom.
What are the main products offered by Axiom Therapeutics?
The flagship platform from Axiom Therapeutics is AI-powered covalent drug discovery for untreatable cancers, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Axiom Therapeutics?
Axiom Therapeutics primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.